Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS)
CNY 15.5
(-1.52%)
CNY 15.5
(-1.52%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 245.55 Million CNY | -4.43% |
| 2022 | 187.81 Million CNY | 3.88% |
| 2021 | 180.79 Million CNY | 16.64% |
| 2020 | 155 Million CNY | -3.34% |
| 2019 | 160.36 Million CNY | 16.7% |
| 2018 | 137.42 Million CNY | -3.44% |
| 2017 | 142.31 Million CNY | -0.12% |
| 2016 | 142.48 Million CNY | 3.08% |
| 2015 | 138.22 Million CNY | 0.65% |
| 2014 | 137.33 Million CNY | 15.45% |
| 2013 | 118.95 Million CNY | 12.16% |
| 2012 | 106.06 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 35.2 Million CNY | -33.26% |
| 2024 Q2 | 51.88 Million CNY | 47.37% |
| 2024 Q3 | 62.15 Million CNY | 53.74% |
| 2023 Q3 | 45.8 Million CNY | 4.3% |
| 2023 Q4 | 52.75 Million CNY | 15.19% |
| 2023 FY | 179.49 Million CNY | -4.43% |
| 2023 Q1 | 37.02 Million CNY | -27.06% |
| 2023 Q2 | 43.91 Million CNY | 18.6% |
| 2022 Q2 | 43.39 Million CNY | 13.72% |
| 2022 Q4 | 50.76 Million CNY | -8.53% |
| 2022 Q3 | 55.49 Million CNY | 27.91% |
| 2022 Q1 | 38.15 Million CNY | -20.31% |
| 2022 FY | 187.81 Million CNY | 3.88% |
| 2021 Q4 | 47.88 Million CNY | 0.83% |
| 2021 FY | 180.79 Million CNY | 16.64% |
| 2021 Q2 | 48.11 Million CNY | 28.92% |
| 2021 Q1 | 37.31 Million CNY | -25.9% |
| 2021 Q3 | 47.48 Million CNY | -1.29% |
| 2020 Q3 | 42.87 Million CNY | 22.79% |
| 2020 Q1 | 26.84 Million CNY | -47.52% |
| 2020 Q2 | 34.91 Million CNY | 30.06% |
| 2020 FY | 155 Million CNY | -3.34% |
| 2020 Q4 | 50.35 Million CNY | 17.45% |
| 2019 Q3 | 39.88 Million CNY | 1.4% |
| 2019 FY | 160.36 Million CNY | 16.7% |
| 2019 Q4 | 51.15 Million CNY | 28.26% |
| 2019 Q1 | 29.99 Million CNY | -25.41% |
| 2019 Q2 | 39.33 Million CNY | 31.15% |
| 2018 Q1 | 25.4 Million CNY | -51.88% |
| 2018 FY | 137.42 Million CNY | -3.44% |
| 2018 Q4 | 40.2 Million CNY | 21.86% |
| 2018 Q3 | 32.99 Million CNY | -14.98% |
| 2018 Q2 | 38.81 Million CNY | 52.78% |
| 2017 FY | 142.31 Million CNY | -0.12% |
| 2017 Q1 | 22.27 Million CNY | -60.6% |
| 2017 Q2 | 38.55 Million CNY | 73.08% |
| 2017 Q3 | 28.69 Million CNY | -25.59% |
| 2017 Q4 | 52.78 Million CNY | 83.98% |
| 2016 FY | 142.48 Million CNY | 3.08% |
| 2016 Q4 | 56.53 Million CNY | 102.33% |
| 2016 Q1 | 20.86 Million CNY | 0.0% |
| 2016 Q2 | 37.14 Million CNY | 78.03% |
| 2016 Q3 | 27.94 Million CNY | -24.78% |
| 2015 FY | 138.22 Million CNY | 0.65% |
| 2014 FY | 137.33 Million CNY | 15.45% |
| 2013 FY | 118.95 Million CNY | 12.16% |
| 2012 FY | 106.06 Million CNY | 0.0% |